Next Article in Journal
STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo
Next Article in Special Issue
TCGA Expression Analyses of 10 Carcinoma Types Reveal Clinically Significant Racial Differences
Previous Article in Journal
Correction: Alkhaleefah et al. Connected-SegNets: A Deep Learning Model for Breast Tumor Segmentation from X-ray Images. Cancers 2022, 14, 4030
Previous Article in Special Issue
Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000–2018
 
 
Article
Peer-Review Record

Lipidomic Profiling Reveals Biological Differences between Tumors of Self-Identified African Americans and Non-Hispanic Whites with Cancer

Cancers 2023, 15(8), 2238; https://doi.org/10.3390/cancers15082238
by April E. Boyd 1, Pamela J. Grizzard 2, Katherine Hylton Rorie 1 and Santiago Lima 1,3,*
Reviewer 1:
Reviewer 2: Anonymous
Cancers 2023, 15(8), 2238; https://doi.org/10.3390/cancers15082238
Submission received: 7 February 2023 / Revised: 27 March 2023 / Accepted: 5 April 2023 / Published: 11 April 2023
(This article belongs to the Special Issue Advancing Health Equity to Reduce Cancer Health Disparities)

Round 1

Reviewer 1 Report

Authors presented lipidomic profiling between African American and Non-Hispanic whites with cancer  and identified a change of lipids between these populations. Authors identified that Sphingolipids may have effect on tumor growth and response to therapy. However, these patients not verified by their ancestry and all are self-reported. 

 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

Tumor incidence and mortality are disproportionately higher in African Americans (AA). In this study, the authors conducted mass spectrometry analyses of sphingolipids in normal adjacent uninvolved tissues and tumors from self-identified AA and non-Hispanic White (NHW) males with cancers of the lung, colon, liver, and head and neck, and of self-identified AA and NHW females with endometrial cancer. They have identified various sphingolipids are altered in race-specific pat-terns, including differential enrichment of ceramides and glucosylceramides of 24:1 and 24:0 fatty acids in tumors. The results are very interesting and the manuscript was well-prepared. The specific comments are listed below.

 

1.     In the Discussion section, the authors have thoroughly elaborated their findings, such as the higher overall relative levels of the 24:1 and 24:0 fatty acid chain-length ceramides in the tumors of AA and its potential contribution to differences in 2416 ceramide ratios. This finding should be properly summarized in the Abstract.

2.     In Materials and Methods, the authors stated that tumor sections with greater than 35% tumor enrichment and tissues determined to be disease-free were selected for lipidomic studies. Should the variations in tumor percentage greatly affect the interpretation of lipidomic analyses? The authors should have addressed this issue.

3.     No author was identified with affiliation #3. Was that a mistake?

Comments for author File: Comments.pdf

Author Response

Please see the attachment

Author Response File: Author Response.docx

Back to TopTop